Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1969 1
1970 1
1971 1
1973 2
1975 1
1978 5
1980 1
1981 3
1982 2
1983 4
1984 5
1985 9
1986 8
1987 16
1988 10
1989 17
1990 18
1991 8
1992 11
1993 23
1994 12
1995 9
1996 13
1997 8
1998 9
1999 17
2000 19
2001 32
2002 35
2003 24
2004 29
2005 37
2006 26
2007 44
2008 41
2009 35
2010 28
2011 26
2012 29
2013 30
2014 22
2015 29
2016 48
2017 43
2018 40
2019 40
2020 38
2021 38
2022 24
2023 33
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

925 results

Results by year

Filters applied: . Clear all
Page 1
Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Miyazaki K, Sakai R, Iwaki N, Yamamoto G, Murayama K, Nishikori M, Sunami K, Yoshida I, Yano H, Takahashi N, Okamoto A, Munemoto S, Sawazaki A, Suehiro Y, Fukuhara N, Wake A, Arai A, Masaki Y, Toyama K, Yokoyama A, Tsunemine H, Hasegawa Y, Matsumoto K, Yamada T, Nishimura Y, Tamaru S, Asano N, Miyawaki K, Izutsu K, Kinoshita T, Suzuki R, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: katayama n. Cancer Sci. 2023 Jun;114(6):2689-2691. doi: 10.1111/cas.15784. Epub 2023 Mar 16. Cancer Sci. 2023. PMID: 36929591 Free PMC article. Clinical Trial. No abstract available.
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study.
Miyazaki K, Asano N, Yamada T, Miyawaki K, Sakai R, Igarashi T, Nishikori M, Ohata K, Sunami K, Yoshida I, Yamamoto G, Takahashi N, Okamoto M, Yano H, Nishimura Y, Tamaru S, Nishikawa M, Izutsu K, Kinoshita T, Suzumiya J, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: katayama n. Haematologica. 2020 Sep 1;105(9):2308-2315. doi: 10.3324/haematol.2019.231076. Haematologica. 2020. PMID: 33054055 Free PMC article. Clinical Trial.
Tertiary lymphoid structures correlate with enhancement of antitumor immunity in esophageal squamous cell carcinoma.
Nakamura S, Ohuchida K, Hayashi M, Katayama N, Tsutsumi C, Yamada Y, Hisano K, Okuda S, Ohtsubo Y, Iwamoto C, Torata N, Mizuuchi Y, Shindo K, Nakata K, Moriyama T, Morisaki T, Oda Y, Nakamura M. Nakamura S, et al. Among authors: katayama n. Br J Cancer. 2023 Oct;129(8):1314-1326. doi: 10.1038/s41416-023-02396-7. Epub 2023 Aug 21. Br J Cancer. 2023. PMID: 37604932
Ontogeny of human B1 cells.
Kageyama Y, Katayama N. Kageyama Y, et al. Among authors: katayama n. Int J Hematol. 2020 May;111(5):628-633. doi: 10.1007/s12185-019-02775-y. Epub 2019 Nov 12. Int J Hematol. 2020. PMID: 31721035 Review.
Statistical Modeling of Subjective Sleep Quality.
Choilek S, Karashima A, Motoike I, Katayama N, Kinoshita K, Nakao M. Choilek S, et al. Among authors: katayama n. Annu Int Conf IEEE Eng Med Biol Soc. 2023 Jul;2023:1-6. doi: 10.1109/EMBC40787.2023.10340638. Annu Int Conf IEEE Eng Med Biol Soc. 2023. PMID: 38083152
Relationship between tinnitus and olfactory dysfunction: audiovisual, olfactory, and medical examinations.
Katayama N, Yoshida T, Nakashima T, Ito Y, Teranishi M, Iwase T, Sugiura S, Goto K, Uchida Y, Taki Y, Nakada T, Tada A, Suzuki H, Nakano Y, Shimono M, Saji N, Kogure A, Shimizu E, Sone M, Hamajima N. Katayama N, et al. Front Public Health. 2023 Apr 20;11:1124404. doi: 10.3389/fpubh.2023.1124404. eCollection 2023. Front Public Health. 2023. PMID: 37151589 Free PMC article.
925 results